Different Clinical Utility of Oropharyngeal Bacterial Screening prior to Percutaneous Endoscopic Gastrostomy in Oncological and Neurological Patients

Table 1

Summary of patient characteristics according to indication for PEG ().

Variable	Neurological disorders ()		Head and neck cancer ()
		%		%
Sex (male)	116	56.3%	45	66.2%	0.159
Colonizing pathogens	159	77.2%	31	45.6%	<0.001*
Polymicrobial flora	75	36.4%	12	17.6%	0.004*
Pathogens resistant to amoxicillin	93	45.1%	12	17.6%	<0.001*
Tracheostomy	67	32.5%	13	19.1%	0.045*
MRSA infection	11	5.3%	0	0.0%	0.071
ATB prophylaxis	206	100.0%	68	100.0%	1.000
Coamoxicillin	196	95.1%	66	97.1%	0.736
Cefuroxim	3	1.5%	1	1.5%	1.000
Other	7	3.4%	1	1.5%	0.684
Serious comorbidities	32	15.5%	7	10.3%	0.324
PEG site infections	18	8.7%	12	17.6%	0.070
Other complications	17	8.3%	12	17.6%	0.040*
Major complications (bleeding, respiratory)	5	2.4%	6	8.8%	0.027*
Minor complications	12	5.8%	6	8.8%	0.394
30 days of mortality	19	9.2%	1	1.5%	0.032*

Statistically significant at 5% level.